NCT05336981 (xeros) is a NA clinical trial of Low-Level Light Therapy in Photobiomodulation, sponsored by Pia Lopez Jornet.

Who is sponsoring NCT05336981?

NCT05336981 is sponsored by Pia Lopez Jornet.

What drugs are being tested in NCT05336981?

Interventions in NCT05336981: Low-Level Light Therapy.

What condition does NCT05336981 study?

NCT05336981 studies Photobiomodulation, Low-Level Light Therapy.

Is NCT05336981 still recruiting?

NCT05336981 is currently completed. Last updated 20 April 2022.

Last reviewed 2022-04-20 · How we verify

NCT05336981: xeros

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effect of Photobiomodulation for Patients With Xerostomia

Completed NA Last updated 20 April 2022

What this trial tests

NA trial testing Low-Level Light Therapy in Photobiomodulation in 60 participants. Completed in 26 January 2022.

Timeline

1 January 2020

Primary endpoint
1 January 2021

26 January 2022

Quick facts

Lead sponsor	Pia Lopez Jornet
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	60
Start date	1 January 2020
Primary completion	1 January 2021
Estimated completion	26 January 2022
Sites	2 locations across Spain

Drugs / interventions tested

Low-Level Light Therapy

Conditions studied

Photobiomodulation — all drugs for Photobiomodulation →
Low-Level Light Therapy — all drugs for Low-Level Light Therapy →

Sponsor

Pia Lopez Jornet — full company profile →

Who can join

18 and older, any sex, with Photobiomodulation or Low-Level Light Therapy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Hyposalivation is a condition represented by a reduced salivary flow and may include symptoms such as mouth dryness (xerostomia), pain, loss of taste,dysphagia, and dysphonia, all of which greatly affect an individual's quality of life. The aim of the present study was analized the effects of low-level light therapy irradiation (photobiomodulation PBM) on salivary gland function in patients with hyposalivation

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Efficacy of Photobiomodulation in Reducing Symptomatology and Improving the Quality of Life in Patients with Xerostomia and Hyposalivation: A Randomized Controlled Trial.
Ferrandez-Pujante A, Pons-Fuster E, López-Jornet P. · · 2022 · cited 9× · PMID 35743485 · DOI 10.3390/jcm11123414

Verify or expand the search:

Other trials of Low-Level Light Therapy

Trials testing the same drug.

NCT07067294 — Effect of Low-Level Light Therapy on Ocular Surface Parameters in Patients Undergoing Cataract Surgery · NA · completed
NCT07181668 — Effect of Low-Level Light Therapy on Ocular Surface Parameters in Patients Undergoing Femto-Lasik Surgery · NA · completed
NCT05816200 — Comparison Between Two Treatments for Burning Mouth · NA · completed

Other recruiting trials for Photobiomodulation

Currently open trials in the same condition.

NCT05935306 — Effect of Photobiomodulation to Reduce Post-operative Pain After Endodontic Surgery · NA · recruiting
NCT05924191 — Preventive Effect of Photobiomodulation in the Postoperative Period of Extractions of Retained Lower Third Molars · NA · recruiting
NCT06536751 — Therapeutic Photobiomodulation and Tretament of Spasticity · Phase 2, PHASE3 · recruiting
NCT05989217 — Conservative Therapies in the Treatment of Temporomandibular Disorders · NA · active not recruiting

Other Pia Lopez Jornet trials

Trials by the same sponsor.

NCT06332365 — Evaluating Treatment Efficacy in Oral Lichen Planus: The Role of Salivary Biomarkers · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05336981 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Pia Lopez Jornet
Last refreshed: 20 April 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05336981.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing